Active Ingredient: NEOSTIGMINE METHYLSULFATE
Proprietary Name: NEOSTIGMINE METHYLSULFATE
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 5MG/10ML (0.5MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A212968
Product Number: 001
Approval Date: Oct 16, 2019
Applicant Holder Full Name: GLAND PHARMA LTD
Marketing Status:
Prescription
Patent and Exclusivity Information